Shared on 26 Jun 26
Fair value Increased 53%ABSI: Interim Hair Loss Data And Financing Will Drive Repricing Ahead
10 viewsusers have viewed this narrative update
Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.
Shared on 26 Jun 26
Fair value Increased 53%Flawless balance sheet with slight risk.
A clinical-stage biopharmaceutical company, develops various antibody therapeutics in the United States.